相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetics of Meloxicam Tablets in Healthy Chinese Adults in the Fasting and Fed States: A Single-Site, Single-Dose, Randomized, Open, 2-Period, 2-Sequence, Crossover Bioequivalence Study
Jin Yu et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2022)
Usage of In Vitro Metabolism Data for Drug-Drug Interaction in Physiologically Based Pharmacokinetic Analysis Submissions to the US Food and Drug Administration
Jieon Lee et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Physiologically based pharmacokinetic modeling of tramadol to inform dose adjustment and drug-drug interactions according to CYP2D6 phenotypes
Miao Xu et al.
PHARMACOTHERAPY (2021)
Meloxicam methyl group determines enzyme specificity for thiazole bioactivation compared to sudoxicam
Dustyn A. Barnette et al.
TOXICOLOGY LETTERS (2021)
Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism
Young-Hoon Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2021)
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach
Lisa Alina Kneller et al.
CLINICAL PHARMACOKINETICS (2021)
Physiologically Based Pharmacokinetic Modelling to Describe the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone According to Cytochrome P450 2D6 Phenotypes
Lisa Alina Kneller et al.
CLINICAL PHARMACOKINETICS (2020)
A protocol of hepatic volume measurement using magnetic resonance imaging in individuals from the Eastern Brazilian Amazon population
Robson Tadachi Moraes de Oliveira et al.
PLOS ONE (2020)
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs
Katherine N. Theken et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Relationship between plasma exposure of zolpidem and CYP2D6 genotype in healthy Korean subjects
Eui Hyun Jung et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
Effects of paroxetine on the pharmacokinetics of atomoxetine and its metabolites in different CYP2D6 genotypes
Eui Hyun Jung et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
Effects of CYP2D6 genetic polymorphism on the pharmacokinetics of metoclopramide
Jung-Woo Bae et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
ABCB1 c.2677G>T/c.3435C>T diplotype increases the early-phase oral absorption of losartan
Hyo-Bin Shin et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
Influence of CYP2D6 genetic polymorphism on pharmacokinetics of active moiety of tolterodine
Ji-Yeong Byeon et al.
ARCHIVES OF PHARMACAL RESEARCH (2019)
Effects of steady-state clarithromycin on the pharmacokinetics of zolpidem in healthy subjects
Choong-Min Lee et al.
ARCHIVES OF PHARMACAL RESEARCH (2019)
Physiologically-based pharmacokinetic modelling of a CYP2C19 substrate, BMS-823778, utilizing pharmacogenetic data
Jiachang Gong et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life
Jan-Frederik Schlender et al.
CLINICAL PHARMACOKINETICS (2018)
Reference values of liver volume in Caucasian population and factors influencing liver size
M. L. Kromrey et al.
EUROPEAN JOURNAL OF RADIOLOGY (2018)
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
Se-Hyung Kim et al.
SCIENTIFIC REPORTS (2018)
Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of celecoxib and its carboxylic acid metabolite
Se-Hyung Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2017)
Physiologically Based Pharmacokinetic (PBPK) Modeling of Pitavastatin and Atorvastatin to Predict Drug-Drug Interactions (DDIs)
Peng Duan et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2017)
How much do clinical trials cost?
Linda Martin et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Pharmacokinetics and Pharmacodynamics of Meloxicam in East Asian Populations: The Role of Ethnicity on Drug Response
Takahiko Aoyama et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)
Absence of ethnic differences in the pharmacokinetics of moxifloxacin, simvastatin, and meloxicam among three East Asian populations and Caucasians
Tomoko Hasunuma et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
PBPK modeling and simulation in drug research and development
Xiaomei Zhuang et al.
ACTA PHARMACEUTICA SINICA B (2016)
Estimation of liver volume in the western Indian population
Gaurav Chaubal et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2016)
Effects of CYP2C9*1/*3 genotype on the pharmacokinetics of flurbiprofen in Korean subjects
Yun-Jeong Lee et al.
ARCHIVES OF PHARMACAL RESEARCH (2015)
Influence of genetic polymorphisms on the pharmacokinetics of celecoxib and its two main metabolites in healthy Chinese subjects
Ruijuan Liu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes
Carolina Cespedes-Garro et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification
Jennifer E. Sager et al.
DRUG METABOLISM AND DISPOSITION (2015)
Effect of CYP2C9*3 mutant variants on meloxicam pharmacokinetics in a healthy Chinese population
M. Zhang et al.
GENETICS AND MOLECULAR RESEARCH (2014)
A formula to calculate the standard liver volume in children and its application in pediatric liver transplantation
Uta Herden et al.
TRANSPLANT INTERNATIONAL (2013)
Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers
Mario Del Tacca et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2013)
Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development
H. M. Jones et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Pharmacokinetic and Bioequivalence Study of Meloxicam Tablets in Healthy Male Subjects
Michael Gschwend et al.
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH (2012)
A Non-extracting Procedure for the Determination of Meloxicam in Plasma Samples by HPLC-Diode Array Detection
Andrei Medvedovici et al.
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH (2012)
CYP2C9*3 and *13 alleles significantly affect the pharmacokinetics of irbesartan in healthy Korean subjects
Chang-Ik Choi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Effects of CYP2C9☆1/☆3 and ☆1/☆13 on the pharmacokinetics of losartan and its active metabolite E-3174
Jung-Woo Bae et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2012)
Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part II: Extension to describe performance of solid dosage forms
Kirstin Thelen et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics
Jung-woo Bae et al.
ACTA PHARMACOLOGICA SINICA (2011)
Effects of the CYP2C9*1/*13 Genotype on the Pharmacokinetics of Lornoxicam
Chang-Ik Choi et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
Effects of CYP2C9*1/*13 on the pharmacokinetics and pharmacodynamics of meloxicam
Jung-Woo Bae et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Evolution of a Detailed Physiological Model to Simulate the Gastrointestinal Transit and Absorption Process in Humans, Part 1: Oral Solutions
Kirstin Thelen et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Worldwide allele frequency distribution of four polymorphisms associated with warfarin dose requirements
Kendra A. Ross et al.
JOURNAL OF HUMAN GENETICS (2010)
Voriconazole Increases while Itraconazole Decreases Plasma Meloxicam Concentrations
V. V. Hynninen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Evaluation of standard liver volume formulae for Chinese adults
Zheng-Rong Shi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
General approach for the calculation of tissue to plasma partition coefficients
Walter Schmitt
TOXICOLOGY IN VITRO (2008)
Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic study
Jung-Woo Bae et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Estimation of standard liver volume in Japanese living liver donors
Takuya Hashimoto et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Investigations on analgesic, anti-inflammatory and ulcerogenic potential of meloxicam solid dispersion prepared with skimmed milk
Dina Nath Mishra et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2006)
Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes
Masuhiro Nishimura et al.
DRUG METABOLISM AND PHARMACOKINETICS (2006)
Bioequivalence evaluation of two brands of meloxicam tablets (Promotion® and Mobicox®):: Pharmacokinetics in a healthy female Mexican population
G Marcelín-Jiménez et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2005)
Further evidence for interethnic differences in the oral pharmacokinetics of meloxicam
MD Carrasco-Portugal et al.
CLINICAL DRUG INVESTIGATION (2005)
Pharmacokinetics of meloxicam in patients with juvenile rheumatoid arthritis
R Burgos-Vargas et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
分享论文
